Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Elara Health and Wellness vs Nucific

Elara Health and Wellness
Graded #33

Higher grade

vs+25.89999999999999
Nucific
Graded #417

Lower grade

The verdict

Elara Health and Wellness takes it — 82.1/100 to 56.2/100.

Elara Health and Wellness grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Low-ish both-molecule pricing ($117/$196), nationwide — but unverified.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueElara Health and Wellness +42
87
45
Dose & formulationElara Health and Wellness +27
80
53
Clinical oversightElara Health and Wellness +3
79
76
Labs & monitoringElara Health and Wellness +26
78
52
FulfillmentElara Health and Wellness +19
86
67
Contract termsElara Health and Wellness +41
82
41
Elara Health and Wellness · left barNucific · right bar

The numbers

MetricElara Health and WellnessNucific
WeighScore82.1/10056.2/100
GradeB−C
Scorecard rank#33#417
Semaglutide$117/moNot disclosed
Tirzepatide$196/moNot disclosed
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
Elara Health and Wellness

Graded #33 · B−

Strengths

  • $117 semaglutide
  • All 50 states
  • Both molecules

Where it loses points

  • Not LegitScript-verified
  • Tirzepatide $196
  • Monitoring detail sparse
Nucific

Graded #417 · C

Strengths

  • Founder is named and credentialed: Dr. Amy Lee, MD, triple board-certified in Internal Medicine, Obesity Medicine and Clinical Nutrition
  • Cites SURMOUNT-1 properly, naming the trial, the 20.9% average and the Jastreboff NEJM 2022 source
  • Discloses that featured patients were compensated for their time
  • Labels its NAD+ decline chart as illustrative and not a measurement, with an unusually careful methodology note
  • Offers compounded, microdosed and brand-name Ozempic and Zepbound in one catalogue

Where it loses points

  • No price is published anywhere; every option is gated behind a three-minute quiz
  • The LegitScript badge is a self-hosted image with generic alt text rather than the issued embed, so the certification could not be verified
  • A BBB Accredited A+ claim is displayed without a link to the BBB profile
  • No state list and no named pharmacy, only licensed U.S. pharmacies
  • Before-and-after photographs are used alongside compensated testimonials

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard